Literature DB >> 8469449

Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer.

S C Plaxe1, P S Braly, J L Freddo, E McClay, S Kirmani, S B Howell.   

Abstract

OBJECTIVE: To study a group of women diagnosed with epithelial ovarian cancer at a young age (less than 40).
METHODS: Tumor registry data were analyzed with respect to age at diagnosis, stage, grade, frequency of nulligravidity, and family history of breast or ovarian cancer. Frequencies were analyzed using contingency tables, and survival distributions were analyzed according to the method of Kaplan and Meier. Multivariate survival analysis was performed with the Cox method.
RESULTS: We found significantly higher frequencies of low-grade tumors (90 versus 37%; P = .0003, chi 2 test) and early-stage tumors (45 versus 17%; P = .03, Fisher exact test) in women less than 30 at the time of diagnosis (very young patients) than in those between 30-39. We also found a significant (P = .017, Breslow statistic) survival advantage for the very young women. Multivariate analysis demonstrated tumor grade as the independent variable for survival.
CONCLUSION: These findings support the concept of a preclinical phase of epithelial carcinoma and show that young women may derive substantial benefit from ovarian cancer screening programs.

Entities:  

Mesh:

Year:  1993        PMID: 8469449

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Fertility preservation in patients with early epithelial ovarian cancer.

Authors:  Yong-Soon Kwon; Ho-Suap Hahn; Tae-Jin Kim; In-Ho Lee; Kyung-Taek Lim; Ki-Heon Lee; Jae-Uk Shim; Jung-Eun Mok
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

2.  A recurrence-predicting prognostic factor for patients with ovarian clear-cell adenocarcinoma at reproductive age.

Authors:  Hiroaki Kajiyama; Mika Mizuno; Kiyosumi Shibata; Tomokazu Umezu; Shiro Suzuki; Eiko Yamamoto; Hiroko Mitsui; Ryuichiro Sekiya; Kaoru Niimi; Michiyasu Kawai; Tetsuro Nagasaka; Fumitaka Kikkawa
Journal:  Int J Clin Oncol       Date:  2013-12-05       Impact factor: 3.402

3.  Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery.

Authors:  H Kajiyama; K Shibata; M Mizuno; T Umezu; S Suzuki; A Nawa; M Kawai; T Nagasaka; F Kikkawa
Journal:  Br J Cancer       Date:  2011-10-04       Impact factor: 7.640

4.  Ovarian cancer in younger vs older women: a population-based analysis.

Authors:  J K Chan; R Urban; M K Cheung; K Osann; J Y Shin; A Husain; N N Teng; D S Kapp; J S Berek; G S Leiserowitz
Journal:  Br J Cancer       Date:  2006-10-31       Impact factor: 7.640

5.  Fertility-Sparing surgery for young women with ovarian endometrioid carcinoma: a multicenteric comparative study using inverse probability of treatment weighting.

Authors:  Hiroaki Kajiyama; Masato Yoshihara; Satoshi Tamauchi; Nobuhisa Yoshikawa; Shiro Suzuki; Fumitaka Kikkawa
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-06-12

6.  Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~.

Authors:  Hiroaki Kajiyama; Shiro Suzuki; Nobuhisa Yoshikawa; Michiyasu Kawai; Kimio Mizuno; Osamu Yamamuro; Tetsuro Nagasaka; Kiyosumi Shibata; Fumitaka Kikkawa
Journal:  BMC Cancer       Date:  2019-12-19       Impact factor: 4.430

7.  Feasibility and safety of fertility-sparing surgery in epithelial ovarian cancer with dense adhesion: a long-term result from a single institution.

Authors:  Min Hyun Baek; Jeong Yeol Park; Dae Yeon Kim; Dae Shik Suh; Jong Hyeok Kim; Yong Man Kim; Young Tak Kim
Journal:  J Gynecol Oncol       Date:  2020-11       Impact factor: 4.401

8.  Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer.

Authors:  Jin-Young Park; Eun Jin Heo; Jeong-Won Lee; Yoo-Young Lee; Tae-Joong Kim; Byoung-Gie Kim; Duk-Soo Bae
Journal:  J Gynecol Oncol       Date:  2016-03       Impact factor: 4.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.